PATENT CLAIM ANALYSIS

Application Number: 16088852
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["546", "270700"]

Abstract:
The invention relates to novel compounds of the Formula (I), to a process for their preparation and to their use as medicaments, in particular as antiviral medicaments.

Claim (Index 14):
The method according to  claim 11 , wherein:\n the disease or disorder associated with viral infections includes herpes infections including Herpes labialis, Herpes genitalis and Herpes-related keratitis, Alzheimers disease, encephalitis, pneumonia, hepatitis, and a suppressed immune system, the effective amount of the compound according to  claim 1  is administered to AIDS patients, cancer patients, patients having a genetic immunodeficiency, transplant patients, new-born children, infants, Herpes-positive patients including Herpes-simplex-positive patients, and the effective amount of the compound for suppresses recurrence of the disease or disorder in patients who are resistant to nucleosidic antiviral therapy including acyclovir, penciclovir, famciclovir, ganciclovir, valacyclovir.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.23077
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14403903', '14419468', '14360905', '14359278', '12394083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7642752655066528
- 35 USC 102 Novelty (BERT): 0.5202444357453472
- Combined Prediction Score: 0.7398721825305222
- Mean Citation Score: 269.8413
- Max Citation Score: 283.72034
- Similarity Product: 181.5928174543047

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test